25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Hubei Biocause Heilen Pharmaceutical Co. Ltd.
Buy, Hold or Sell?

Let's analyze Biocause together

I guess you are interested in Hubei Biocause Heilen Pharmaceutical Co. Ltd.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Hubei Biocause Heilen Pharmaceutical Co. Ltd.

I send you an email if I find something interesting about Hubei Biocause Heilen Pharmaceutical Co. Ltd..

1. Quick Overview

1.1. Quick analysis of Biocause (30 sec.)










1.2. What can you expect buying and holding a share of Biocause? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
¥7.95
Expected worth in 1 year
¥7.92
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
¥-0.01
Return On Investment
-0.1%

For what price can you sell your share?

Current Price per Share
¥20.61
Expected price per share
¥14.73 - ¥26.22
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biocause (5 min.)




Live pricePrice per Share (EOD)
¥20.61

2.2. Growth of Biocause (5 min.)




Is Biocause growing?

Current yearPrevious yearGrowGrow %
How rich?$316.2m$314.9m$8.6m2.7%

How much money is Biocause making?

Current yearPrevious yearGrowGrow %
Making money$4.5m$6.3m-$1.8m-40.1%
Net Profit Margin26.6%26.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Biocause (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biocause?

Welcome investor! Biocause's management wants to use your money to grow the business. In return you get a share of Biocause.

First you should know what it really means to hold a share of Biocause. And how you can make/lose money.

Speculation

The Price per Share of Biocause is ¥20.61. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biocause.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biocause, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.95. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biocause.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.020.1%0.020.1%0.020.1%0.020.1%
Usd Book Value Change Per Share-0.05-0.2%0.000.0%0.000.0%0.110.5%0.110.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-0.2%0.000.0%0.000.0%0.110.5%0.110.5%
Usd Price Per Share2.02-2.67-3.63-3.18-3.18-
Price to Earnings Ratio33.81-42.61-44.78-47.64-47.64-
Price-to-Total Gains Ratio-39.43-124.34--1.63-73.04-73.04-
Price to Book Ratio1.84-2.37-3.31-2.88-2.88-
Price-to-Total Gains Ratio-39.43-124.34--1.63-73.04-73.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.848302
Number of shares351
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.11
Usd Total Gains Per Share0.000.11
Gains per Quarter (351 shares)-0.1838.58
Gains per Year (351 shares)-0.70154.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1-110154144
21-2-120308298
31-3-130462452
41-4-141617606
52-5-151771760
62-6-161925914
73-7-17110791068
83-9-18112331222
93-10-19113871376
104-11-20115421530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%7.03.00.070.0%7.03.00.070.0%7.03.00.070.0%7.03.00.070.0%
Dividend per Share1.00.03.025.0%1.00.09.010.0%1.00.09.010.0%1.00.09.010.0%1.00.09.010.0%
Total Gains per Share3.01.00.075.0%7.03.00.070.0%7.03.00.070.0%7.03.00.070.0%7.03.00.070.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Hubei Biocause Heilen Pharmaceutical Co. Ltd. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.371-0.005-99%0.015-2557%0.795-147%0.795-147%
Book Value Per Share--7.9458.131-2%7.914+0%7.990-1%7.990-1%
Current Ratio--14.97313.921+8%15.776-5%16.093-7%16.093-7%
Debt To Asset Ratio--0.0580.065-11%0.068-14%0.062-7%0.062-7%
Debt To Equity Ratio--0.0610.069-11%0.073-16%0.066-8%0.066-8%
Dividend Per Share---0.002-100%-0%0.001-100%0.001-100%
Eps--0.1080.114-5%0.160-32%0.129-16%0.129-16%
Free Cash Flow Per Share---0.059-0.082+40%0.061-197%0.023-359%0.023-359%
Free Cash Flow To Equity Per Share---0.059-0.082+40%0.061-197%0.023-359%0.023-359%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap5935680000.000+29%4207680000.0005561280000.000-24%7561440000.000-44%6631488000.000-37%6631488000.000-37%
Net Profit Margin--0.3000.266+13%0.265+13%0.258+16%0.258+16%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.5621.462+7%1.441+8%1.479+6%1.479+6%
Pb Ratio2.594+29%1.8392.374-23%3.311-44%2.885-36%2.885-36%
Pe Ratio47.692+29%33.80842.610-21%44.778-24%47.637-29%47.637-29%
Price Per Share20.610+29%14.61019.310-24%26.255-44%23.026-37%23.026-37%
Price To Free Cash Flow Ratio-87.543-41%-62.057-898.517+1348%37.119-267%-336.394+442%-336.394+442%
Price To Total Gains Ratio-55.623-41%-39.430124.337-132%-1.633-96%73.039-154%73.039-154%
Quick Ratio--5.2682.243+135%1.023+415%1.493+253%1.493+253%
Return On Assets--0.0130.013-2%0.019-31%0.015-15%0.015-15%
Return On Equity--0.0140.014-3%0.020-33%0.016-15%0.016-15%
Total Gains Per Share---0.371-0.004-99%0.015-2557%0.795-147%0.795-147%
Usd Book Value--316232456.416323614905.747-2%314996519.754+0%318020348.612-1%318020348.612-1%
Usd Book Value Change Per Share---0.051-0.001-99%0.002-2557%0.110-147%0.110-147%
Usd Book Value Per Share--1.0981.124-2%1.094+0%1.104-1%1.104-1%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps--0.0150.016-5%0.022-32%0.018-16%0.018-16%
Usd Free Cash Flow---2342591.863-3268868.473+40%2426544.237-197%905687.186-359%905687.186-359%
Usd Free Cash Flow Per Share---0.008-0.011+40%0.008-197%0.003-359%0.003-359%
Usd Free Cash Flow To Equity Per Share---0.008-0.011+40%0.008-197%0.003-359%0.003-359%
Usd Market Cap820310976.000+29%581501376.000768568896.000-24%1044991008.000-44%916471641.600-37%916471641.600-37%
Usd Price Per Share2.848+29%2.0192.669-24%3.628-44%3.182-37%3.182-37%
Usd Profit--4300012.0304545859.055-5%6369771.487-32%5118045.253-16%5118045.253-16%
Usd Revenue--14346242.71317245088.299-17%23504164.277-39%19621699.549-27%19621699.549-27%
Usd Total Gains Per Share---0.051-0.001-99%0.002-2557%0.110-147%0.110-147%
 EOD+4 -4MRQTTM+13 -21YOY+11 -215Y+7 -2710Y+7 -27

3.3 Fundamental Score

Let's check the fundamental score of Hubei Biocause Heilen Pharmaceutical Co. Ltd. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1547.692
Price to Book Ratio (EOD)Between0-12.594
Net Profit Margin (MRQ)Greater than00.300
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.268
Current Ratio (MRQ)Greater than114.973
Debt to Asset Ratio (MRQ)Less than10.058
Debt to Equity Ratio (MRQ)Less than10.061
Return on Equity (MRQ)Greater than0.150.014
Return on Assets (MRQ)Greater than0.050.013
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Hubei Biocause Heilen Pharmaceutical Co. Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.198
Ma 20Greater thanMa 5021.283
Ma 50Greater thanMa 10017.823
Ma 100Greater thanMa 20016.311
OpenGreater thanClose20.510
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Hubei Biocause Heilen Pharmaceutical Co. Ltd.

Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China and internationally. The company provides APIs and intermediates, and formulations; and dimethyl ether gas and a-chloropropionyl chloride chemical products. It is also involved in the contract research, manufacture, and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc. The company was founded in 1995 and is based in Jingmen, China.

Fundamental data was last updated by Penke on 2024-11-12 09:31:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biocause earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Biocause to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 30.0% means that ¥0.30 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 30.0%. The company is making a huge profit. +2
  • The TTM is 26.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ30.0%TTM26.6%+3.4%
TTM26.6%YOY26.5%+0.1%
TTM26.6%5Y25.8%+0.8%
5Y25.8%10Y25.8%0.0%
4.3.1.2. Return on Assets

Shows how efficient Biocause is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biocause to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.3% Return on Assets means that Biocause generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.3%0.0%
TTM1.3%YOY1.9%-0.6%
TTM1.3%5Y1.5%-0.2%
5Y1.5%10Y1.5%0.0%
4.3.1.3. Return on Equity

Shows how efficient Biocause is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biocause to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.4% Return on Equity means Biocause generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 1.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.4%TTM1.4%0.0%
TTM1.4%YOY2.0%-0.6%
TTM1.4%5Y1.6%-0.2%
5Y1.6%10Y1.6%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Hubei Biocause Heilen Pharmaceutical Co. Ltd..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biocause is operating .

  • Measures how much profit Biocause makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biocause to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Biocause is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are ¥1.56 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 1.562. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.462. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.562TTM1.462+0.100
TTM1.462YOY1.441+0.021
TTM1.4625Y1.479-0.017
5Y1.47910Y1.4790.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Hubei Biocause Heilen Pharmaceutical Co. Ltd..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biocause is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 14.97 means the company has ¥14.97 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 14.973. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.921. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.973TTM13.921+1.053
TTM13.921YOY15.776-1.856
TTM13.9215Y16.093-2.173
5Y16.09310Y16.0930.000
4.4.3.2. Quick Ratio

Measures if Biocause is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biocause to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 5.27 means the company can pay off ¥5.27 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 5.268. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.243. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.268TTM2.243+3.025
TTM2.243YOY1.023+1.220
TTM2.2435Y1.493+0.750
5Y1.49310Y1.4930.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Hubei Biocause Heilen Pharmaceutical Co. Ltd..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biocause assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biocause to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.06 means that Biocause assets are financed with 5.8% credit (debt) and the remaining percentage (100% - 5.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 0.058. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.065. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.058TTM0.065-0.007
TTM0.065YOY0.068-0.003
TTM0.0655Y0.062+0.003
5Y0.06210Y0.0620.000
4.5.4.2. Debt to Equity Ratio

Measures if Biocause is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biocause to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 6.1% means that company has ¥0.06 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The MRQ is 0.061. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.069. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.061TTM0.069-0.008
TTM0.069YOY0.073-0.004
TTM0.0695Y0.066+0.003
5Y0.06610Y0.0660.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Biocause generates.

  • Above 15 is considered overpriced but always compare Biocause to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 33.81 means the investor is paying ¥33.81 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The EOD is 47.692. Based on the earnings, the company is overpriced. -1
  • The MRQ is 33.808. Based on the earnings, the company is overpriced. -1
  • The TTM is 42.610. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD47.692MRQ33.808+13.884
MRQ33.808TTM42.610-8.802
TTM42.610YOY44.778-2.168
TTM42.6105Y47.637-5.027
5Y47.63710Y47.6370.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The EOD is -87.543. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -62.057. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -898.517. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-87.543MRQ-62.057-25.486
MRQ-62.057TTM-898.517+836.459
TTM-898.517YOY37.119-935.636
TTM-898.5175Y-336.394-562.123
5Y-336.39410Y-336.3940.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biocause is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hubei Biocause Heilen Pharmaceutical Co. Ltd.:

  • The EOD is 2.594. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.839. Based on the equity, the company is underpriced. +1
  • The TTM is 2.374. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.594MRQ1.839+0.755
MRQ1.839TTM2.374-0.535
TTM2.374YOY3.311-0.937
TTM2.3745Y2.885-0.511
5Y2.88510Y2.8850.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,428,819
Total Liabilities140,596
Total Stockholder Equity2,288,223
 As reported
Total Liabilities 140,596
Total Stockholder Equity+ 2,288,223
Total Assets = 2,428,819

Assets

Total Assets2,428,819
Total Current Assets1,901,027
Long-term Assets527,793
Total Current Assets
Cash And Cash Equivalents 1,022,662
Short-term Investments 598,066
Net Receivables 70,787
Inventory 180,162
Other Current Assets 7,966
Total Current Assets  (as reported)1,901,027
Total Current Assets  (calculated)1,879,644
+/- 21,383
Long-term Assets
Property Plant Equipment 440,460
Intangible Assets 70,021
Long-term Assets Other 3,927
Long-term Assets  (as reported)527,793
Long-term Assets  (calculated)514,408
+/- 13,385

Liabilities & Shareholders' Equity

Total Current Liabilities126,961
Long-term Liabilities13,635
Total Stockholder Equity2,288,223
Total Current Liabilities
Accounts payable 85,196
Other Current Liabilities 5,323
Total Current Liabilities  (as reported)126,961
Total Current Liabilities  (calculated)90,518
+/- 36,442
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt4,064
Long-term Liabilities  (as reported)13,635
Long-term Liabilities  (calculated)4,064
+/- 9,572
Total Stockholder Equity
Retained Earnings 192,456
Total Stockholder Equity (as reported)2,288,223
Total Stockholder Equity (calculated)192,456
+/- 2,095,767
Other
Capital Stock288,000
Common Stock Shares Outstanding 288,000
Net Invested Capital 2,288,223
Net Working Capital 1,774,066
Property Plant and Equipment Gross 440,460



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
2,361,084
2,382,183
2,313,137
2,497,721
2,480,787
2,492,508
2,498,883
2,546,571
2,542,264
2,428,819
2,428,8192,542,2642,546,5712,498,8832,492,5082,480,7872,497,7212,313,1372,382,1832,361,084
   > Total Current Assets 
2,162,761
2,181,997
2,095,406
2,226,895
2,198,104
2,142,682
2,119,187
2,098,949
2,062,715
1,901,027
1,901,0272,062,7152,098,9492,119,1872,142,6822,198,1042,226,8952,095,4062,181,9972,162,761
       Cash And Cash Equivalents 
1,912,291
1,943,415
1,889,355
1,858,089
1,825,739
1,730,192
1,729,397
1,694,327
1,663,102
1,022,662
1,022,6621,663,1021,694,3271,729,3971,730,1921,825,7391,858,0891,889,3551,943,4151,912,291
       Short-term Investments 
0
0
0
103,976
103,976
125,380
125,380
129,400
119,308
598,066
598,066119,308129,400125,380125,380103,976103,976000
       Net Receivables 
103,978
88,777
72,222
71,675
70,892
94,867
73,392
52,445
70,319
70,787
70,78770,31952,44573,39294,86770,89271,67572,22288,777103,978
       Inventory 
90,922
115,870
96,939
114,702
122,046
124,563
132,774
173,805
167,614
180,162
180,162167,614173,805132,774124,563122,046114,70296,939115,87090,922
       Other Current Assets 
756
1,987
185
1,205
1,141
2,900
2,909
9,601
6,018
7,966
7,9666,0189,6012,9092,9001,1411,2051851,987756
   > Long-term Assets 
198,323
200,186
217,732
270,826
282,683
349,826
379,696
447,622
479,549
527,793
527,793479,549447,622379,696349,826282,683270,826217,732200,186198,323
       Property Plant Equipment 
0
0
0
0
192,247
238,845
277,251
361,991
397,521
440,460
440,460397,521361,991277,251238,845192,2470000
       Intangible Assets 
66,179
65,692
73,629
73,275
72,745
72,161
71,604
71,071
70,577
70,021
70,02170,57771,07171,60472,16172,74573,27573,62965,69266,179
       Long-term Assets Other 
1,240
1,720
1,720
11,469
15,981
36,381
27,863
11,032
7,995
3,927
3,9277,99511,03227,86336,38115,98111,4691,7201,7201,240
> Total Liabilities 
110,344
105,008
83,811
221,222
164,040
197,960
172,160
189,886
147,328
140,596
140,596147,328189,886172,160197,960164,040221,22283,811105,008110,344
   > Total Current Liabilities 
105,830
100,503
79,315
208,909
151,736
185,666
159,874
175,141
133,340
126,961
126,961133,340175,141159,874185,666151,736208,90979,315100,503105,830
       Accounts payable 
39,132
45,282
26,547
82,621
60,195
95,161
87,924
117,695
91,732
85,196
85,19691,732117,69587,92495,16160,19582,62126,54745,28239,132
       Other Current Liabilities 
19,236
12,312
7,634
21,032
26,453
20,577
15,629
11,105
8,682
5,323
5,3238,68211,10515,62920,57726,45321,0327,63412,31219,236
   > Long-term Liabilities 
4,514
4,505
4,496
12,313
12,303
12,294
12,285
14,745
13,988
13,635
13,63513,98814,74512,28512,29412,30312,3134,4964,5054,514
> Total Stockholder Equity
2,250,740
2,277,174
2,229,327
2,276,499
2,316,747
2,294,547
2,326,723
2,356,685
2,394,936
2,288,223
2,288,2232,394,9362,356,6852,326,7232,294,5472,316,7472,276,4992,229,3272,277,1742,250,740
   Common Stock0000000000
   Retained Earnings 
184,102
210,536
162,689
198,438
238,361
215,477
246,953
262,200
299,582
192,456
192,456299,582262,200246,953215,477238,361198,438162,689210,536184,102
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 0000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue663,026
Cost of Revenue-396,675
Gross Profit266,351266,351
 
Operating Income (+$)
Gross Profit266,351
Operating Expense-513,101
Operating Income149,925-246,750
 
Operating Expense (+$)
Research Development52,775
Selling General Administrative36,911
Selling And Marketing Expenses0
Operating Expense513,10189,686
 
Net Interest Income (+$)
Interest Income47,836
Interest Expense-307
Other Finance Cost-269
Net Interest Income47,260
 
Pretax Income (+$)
Operating Income149,925
Net Interest Income47,260
Other Non-Operating Income Expenses0
Income Before Tax (EBT)202,816149,925
EBIT - interestExpense = -307
176,116
176,424
Interest Expense307
Earnings Before Interest and Taxes (EBIT)0203,124
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax202,816
Tax Provision-26,700
Net Income From Continuing Ops176,116176,116
Net Income176,116
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-47,260
 

Technical Analysis of Biocause
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biocause. The general trend of Biocause is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biocause's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hubei Biocause Heilen Pharmaceutical Co. Ltd..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 25.23 < 25.77 < 26.22.

The bearish price targets are: 16.03 > 15.00 > 14.73.

Tweet this
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current macd is 0.80426464.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biocause price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biocause. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biocause price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Moving Average Convergence/Divergence (MACD) ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current adx is 47.29.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biocause shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current sar is 25.18.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current rsi is 53.20. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Relative Strength Index (RSI) ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biocause price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Stochastic Oscillator ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current cci is -45.54641374.

Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Commodity Channel Index (CCI) ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current cmo is -2.91374772.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Chande Momentum Oscillator (CMO) ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current willr is -85.00823723.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Williams %R ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hubei Biocause Heilen Pharmaceutical Co. Ltd..

Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current atr is 1.32465135.

Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Average True Range (ATR) ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current obv is 393,643,639.

Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily On-Balance Volume (OBV) ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hubei Biocause Heilen Pharmaceutical Co. Ltd.. The current mfi is 59.96.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Money Flow Index (MFI) ChartHubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hubei Biocause Heilen Pharmaceutical Co. Ltd..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Hubei Biocause Heilen Pharmaceutical Co. Ltd. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hubei Biocause Heilen Pharmaceutical Co. Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.198
Ma 20Greater thanMa 5021.283
Ma 50Greater thanMa 10017.823
Ma 100Greater thanMa 20016.311
OpenGreater thanClose20.510
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biocause with someone you think should read this too:
  • Are you bullish or bearish on Biocause? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biocause? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hubei Biocause Heilen Pharmaceutical Co. Ltd.

I send you an email if I find something interesting about Hubei Biocause Heilen Pharmaceutical Co. Ltd..


Comments

How you think about this?

Leave a comment

Stay informed about Hubei Biocause Heilen Pharmaceutical Co. Ltd..

Receive notifications about Hubei Biocause Heilen Pharmaceutical Co. Ltd. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.